Cozaar Tablet, Film Coated
Product Images NDC 78206-123

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Cozaar (NDC 78206-123). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Organon Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Cozaar 01)

Chemical structure of losartan potassium, the active ingredient in COZAAR tablets. The diagram shows the molecular framework including key functional groups and potassium ion associated with the molecule.*

FDA Label Image

Figure 1 (Cozaar 02)

A line graph comparing the percentage of patients with a primary endpoint over study months between atenolol and COZAAR (losartan potassium). The x-axis shows the study month up to 66 months and the y-axis represents the percentage of patients with the primary endpoint up to 16%. The graph indicates an adjusted risk reduction of 13% with a p-value of 0.021 in favor of COZAAR.*

FDA Label Image

Figure 2 (Cozaar 03)

A line graph comparing the percentage of patients with fatal and non-fatal stroke over 66 study months for Atenolol and COZAAR (losartan potassium). The graph shows risk reduction with COZAAR, including a noted adjusted risk reduction of 25% (p=0.001). The x-axis represents study months, and the y-axis shows the percentage of patients with stroke.*

FDA Label Image

Figure 3 (Cozaar 04)

A forest plot chart comparing COZAAR and Atenolol event rates and hazard ratios for primary composite and stroke outcomes across patient subgroups, including overall results, age, gender, race, ISH, diabetes, and history of cardiovascular disease. The chart visually displays hazard ratios with 95% confidence intervals, indicating treatment effects with proportional symbols representing sample sizes.*

FDA Label Image

Figure 4 (Cozaar 05)

A line graph comparing the percentage of patients with an event over 48 months for COZAAR (losartan potassium) versus placebo. The graph shows two lines, one solid for COZAAR and one dotted for placebo, with annotations noting a risk reduction of 16.1% and a p-value of 0.022.*

FDA Label Image

Principal Display Panel (25 mg Tablet Bottle Label)

Label for COZAAR 25 mg film-coated tablets containing losartan potassium. The label shows the strength as 25 mg and states 90 tablets per package. It is manufactured by Organon LLC, a subsidiary of Organon & Co., with storage instructions and a barcode on the left side. The label features the Organon logo and a note regarding dosage instructions and serialization encoding area.*

FDA Label Image

Principal Display Panel (50 mg Tablet Bottle Label)

Cozaar 50 mg film-coated tablets label showing the brand name, generic name losartan potassium, strength 50 mg, and quantity of 30 tablets. The label includes manufacturer Organon LLC information, storage instructions, a barcode, and an image of an oval tablet imprinted with "952." The label design features a black and white layout with a space reserved for serialization and lot details.*

FDA Label Image

Principal Display Panel (100 mg Tablet Bottle Label)

COZAAR 100 mg (losartan potassium) film-coated tablets packaging label from Organon LLC. The label shows a white, oval tablet embossed with '960' and features dosage instructions, storage conditions, and prescription-only designation. The package contains 30 tablets and includes barcode and serialization space.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.